Chittajallu R S, Dorrian C A, Neithercut W D, Dahill S, McColl K E
University Department of Medicine and Therapeutics, Western Infirmary, Glasgow.
Gut. 1991 Nov;32(11):1286-90. doi: 10.1136/gut.32.11.1286.
Eradication of Helicobacter pylori is associated with a fall in serum gastrin but the way in which the infection raises the serum gastrin concentration is not clear. It may be related to the ammonia produced by the bacterium's urease stimulating gastrin release by the antral G cells. Alternatively, the antral gastritis induced by the infection may modify the regulation of gastrin release. We have examined serum gastrin in 10 patients before and 24 hours after starting triple anti-H pylori treatment consisting of tripotassium dicitrato bismuthate 120 mg four times daily, metronidazole 400 mg three times daily, and amoxycillin 500 mg three times daily. The urease activity, assessed by the 20 minute value of the 14C-urea breath test, fell from a median of 176 (range 116-504) kg% dose/mmol CO2 x 100 pretreatment to 5 (2-15) at 24 hours (p less than 0.005). The median antral gastritis score was 6 (4-6) pretreatment and fell to 3 (2-5) at 24 hours (p less than 0.02), and this was due to resolution of the polymorphonuclear component. Despite this complete suppression of bacterial urease activity and partial resolution of antral gastritis the median basal gastrin concentration remained unchanged, being 57 ng/l (45-77) pretreatment and 59 ng/l (45-80) at 24 hours and the median integrated gastrin response to a standardised meal was also unaltered, being 4265 ng/l/min (range 1975-8350) and 4272 ng/l/min (range 2075-6495) respectively. These findings do not support a causal association between H pylori urease activity and hypergastrinaemia and show rapid improvement of antral gastritis after starting anti-H pylori treatment.
根除幽门螺杆菌与血清胃泌素水平下降有关,但该感染升高血清胃泌素浓度的方式尚不清楚。这可能与细菌脲酶产生的氨刺激胃窦G细胞释放胃泌素有关。或者,感染引起的胃窦胃炎可能会改变胃泌素释放的调节。我们对10例患者在开始三联抗幽门螺杆菌治疗前及治疗24小时后检测了血清胃泌素水平,治疗方案为:枸橼酸铋钾120mg,每日4次;甲硝唑400mg,每日3次;阿莫西林500mg,每日3次。通过14C-尿素呼气试验20分钟的值评估的脲酶活性,从治疗前的中位数176(范围116 - 504)kg%剂量/mmol CO2×100降至24小时时的5(2 - 15)(p<0.005)。胃窦胃炎评分中位数治疗前为6(4 - 6),24小时时降至3(2 - 5)(p<0.02),这是由于多形核细胞成分消退所致。尽管细菌脲酶活性被完全抑制且胃窦胃炎部分缓解,但基础胃泌素浓度中位数保持不变,治疗前为57 ng/l(45 - 77),24小时时为59 ng/l(45 - 80),对标准化餐的胃泌素综合反应中位数也未改变,分别为4265 ng/l/min(范围1975 - 8350)和4272 ng/l/min(范围2075 - 6495)。这些发现不支持幽门螺杆菌脲酶活性与高胃泌素血症之间存在因果关系,并显示开始抗幽门螺杆菌治疗后胃窦胃炎迅速改善。